Bernard Durante, MD
Otolaryngic Allergy · Bourne, MANPI 1164400040
Payments from drug & device makers
Across 38 payments — averaging $70.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Intersect ENT, Inc.$253
- Stryker$193
- Alk-abello, Inc$106
- GSK$101
- Genentech USA, Inc.$98
- plus $102 from 5 others
What the payments were for
- Travel & lodging$1,39652%
- Food & beverage$1,25847%
- Education$161%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 12 | $1,817 |
| Intersect ENT, Inc. | 4 | $253 |
| Stryker | 4 | $193 |
| Alk-abello, Inc | 6 | $106 |
| GSK | 2 | $101 |
| Genentech USA, Inc. | 5 | $98 |
| Greer Laboratories, Inc. | 1 | $31 |
| Sanofi | 1 | $22 |
| Smith+Nephew | 1 | $22 |
| Resmed Corp | 1 | $16 |
| Aerin Medical Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QUADCUT$1,055
- PROPEL$271
- StealthStation$259
- SPIROX - LATERA$168
- STEALTHSTATION S8 PLATFORM$138
How this compares
Too few otolaryngic allergy providers in Massachusettsto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 32 | $133,766 |
| XolairOmalizumab | 21 | $77,582 |
| Azelastine Hcl | 703 | $26,798 |
| Fluticasone Propionate | 852 | $13,848 |
| Ipratropium Bromide | 399 | $10,158 |
| Dexlansoprazole DrDexlansoprazole | 12 | $5,771 |
| Famotidine | 490 | $5,622 |
| Ofloxacin | 119 | $5,225 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 38 | $4,687 |
| Omeprazole | 355 | $4,420 |
| Dexamethasone Sodium Phosphate | 104 | $4,196 |
| Montelukast Sodium | 73 | $1,353 |
| Fluocinonide | 44 | $1,281 |
| Pantoprazole Sodium | 98 | $1,196 |
| Fluocinolone Acetonide Oil | 19 | $1,049 |
Paid to pharmacies, not to this prescriber.
Other otolaryngic allergy in Bourne
- Anit PatelPlymouth$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.